1-2 of 2
Marina Able
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Potent Activity of Duocarmyin- and Mmaf-Conjugated FLT3-Directed Antibody-Drug Conjugates Towards Acute Myeloid Leukemia Stem Cells in Vitro and In Vivo

Marina Able, Marc-André Kasper, Binje Vick, Jonathan Schwach, Xiang Gao, Saskia Schmitt, Belay Tizazu, Amrei Fischer, Sarah Künzl, Marit Leilich, Isabelle Mai, Philipp Ochtrop, Andreas Stengl, Mark A.R. de Geus, Michael von Bergwelt-Baildon, Dominik Schumacher, Jonas Helma, Katharina S. S. Götze, Irmela Jeremias, Michaela Feuring, Karsten Spiekermann
Journal: Blood
Blood (2024) 144 (Supplement 1): 1392.
https://doi.org/10.1182/blood-2024-206832
Published: 2024
Journal Articles

Targeting FLT3 with a new-generation antibody-drug conjugate in combination with kinase inhibitors for treatment of AML

Maike Roas, Binje Vick, Marc-André Kasper, Marina Able, Harald Polzer, Marcus Gerlach, Elisabeth Kremmer, Judith S. Hecker, Saskia Schmitt, Andreas Stengl, Verena Waller, Natascha Hohmann, Moreno Festini, Alexander Ludwig, Lisa Rohrbacher, Tobias Herold, Marion Subklewe, Katharina S. Götze, Christian P. R. Hackenberger, Dominik Schumacher, Jonas Helma-Smets, Irmela Jeremias, Heinrich Leonhardt, Karsten Spiekermann
Journal: Blood
Blood (2023) 141 (9): 1023–1035.
https://doi.org/10.1182/blood.2021015246
Published: 2023
Includes: Supplemental data